![]() |
市場調查報告書
商品編碼
1876752
寵物CBD產品市場預測至2032年:按產品、頻譜、寵物類型、應用、通路和地區分類的全球分析Pet CBD Products Market Forecasts to 2032 - Global Analysis By Product (Oils & Tinctures, Treats & Chews, Capsules & Softgels and Supplements), Spectrum, Pet Type, Application, Distribution Channel and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球寵物 CBD 產品市場價值將達到 8.741 億美元,到 2032 年將達到 27.846 億美元,在預測期內的複合年成長率為 18.0%。
寵物專用CBD產品是源自大麻的配方,旨在支持寵物(例如犬貓)的健康和福祉。這些產品含有大麻二酚(CBD),這是一種非精神活性化合物,以其潛在的治療益處而聞名,包括緩解焦慮、發炎、疼痛和癲癇發作。寵物專用CBD產品有多種形式,包括油劑、零食、膠囊、咀嚼片和外用產品,安全合法(THC含量低於0.3%),且配方適口,動物偏好。在獸醫的指導下,這些產品擴大被用於寵物整體護理方案中,以提高寵物的生命品質並控制慢性疾病,且不會產生任何致幻作用。
寵物擬人化與健康趨勢
寵物日益擬人化是寵物CBD產品市場的主要驅動力,因為飼主主人越來越傾向於尋求寵物健康的整體解決方案。 CBD產品被認為是一種天然的替代療法,可以緩解焦慮、疼痛和老齡化相關症狀。隨著寵物被視為家庭成員,對安全、無成癮性和治療性配方的需求持續成長。這種消費行為的轉變,加上寵物醫療保健支出不斷增加,正迅速推動已開發經濟體和新興經濟體的市場擴張。
監理不確定性
監管的不確定性仍是寵物CBD產品市場的主要阻礙因素。各國和各州不同的法律體制導致產品核准、標籤和分銷方面存在不確定性。缺乏動物CBD使用方面的標準化指南限制了獸醫的建議和消費者的信心。此外,執法不一致和不斷變化的法規阻礙了新進入者的市場准入,並使擴大策略變得複雜。在更明確的法規訂定之前,這種不確定性將繼續給尋求可靠CBD解決方案的製造商、零售商和寵物飼主帶來挑戰。
產品創新與品牌塑造
產品創新和品牌建立為寵物CBD產品市場帶來了巨大的成長機會。各公司正在開發多種產品形式,包括調味零食、油劑、膠囊和外用產品,以滿足寵物的偏好和健康需求。加強品牌建立策略,例如提高成分來源的透明度和進行第三方檢測,將有助於建立消費者的信任和忠誠度。隨著人們對CBD益處的認知不斷提高,針對特定症狀(例如關節疼痛、焦慮)的創新給藥系統和配方正在推動產品差異化。這波創新浪潮有望加速CBD產品的普及,並擴大市場覆蓋範圍。
獸醫建議有限
獸醫認可度有限對寵物CBD產品市場構成威脅。由於缺乏臨床數據和監管風險,許多專家仍持謹慎態度。缺乏強而有力的獸醫支持,寵物飼主可能不願意使用CBD產品,尤其是在寵物患有慢性病或嚴重的情況下。這種醫學支援的缺失影響了產品的可信度,並阻礙了其被大眾廣泛接受。為了克服這一障礙,企業必須加強研發、教育投入,並與獸醫組織合作,以建立循證支持並推廣負責任的使用。
新冠疫情對寵物CBD產品市場產生了複雜的影響。雖然供應鏈中斷和經濟不確定性最初減緩了市場成長,但寵物飼養量的增加和居家時間的延長推動了人們對健康解決方案的需求。飼主更加關注寵物的行為和健康問題,從而帶動了對舒緩和治療性CBD產品的需求。疫情封鎖期間,電子商務通路蓬勃發展,改變了消費者的購買習慣,並擴大了產品的取得管道。疫情後的復甦繼續支撐著市場的發展勢頭,數位平台和健康意識增強的消費者將推動市場實現持續的長期成長。
預計在預測期內,CBD隔離群市場將佔據最大的市場佔有率。
由於其純度高、均一且符合法律法規,CBD隔離群物預計將在預測期內佔據最大的市場佔有率。隔離群配方含有99%的純CBD,不含THC和其他大麻素,因此非常適合寵物使用。這些產品劑量可預測,且精神活性作用風險極低,因此深受謹慎的寵物飼主和獸醫的青睞。此外,它們還以多種形式供應,包括零食、油劑和膠囊,這進一步鞏固了其市場主導地位,尤其是在監管標準嚴格的地區。
預計在預測期內,電子商務領域將呈現最高的複合年成長率。
預計在預測期內,電子商務領域將保持最高的成長率,這主要得益於其便利性、產品多樣性和日益增強的數位意識。線上平台不僅方便消費者購買CBD產品,還提供豐富的教育內容、使用者評價和訂閱服務。疫情加速了數位化進程,消費者更傾向於直接配送寵物保健產品。電子商務也幫助小眾品牌繞過傳統零售通路,觸達全球客戶。這種消費行為的轉變預計將持續推動電子商務的快速成長,並重塑分銷策略。
由於寵物擁有率上升、可支配收入增加以及人們對天然療法的認知不斷提高,預計亞太地區將在預測期內佔據最大的市場佔有率。在中國、日本和印度等國家,寵物人性化程度的提高推動了對整體護理產品的需求。不斷擴展的電子商務基礎設施和有利的監管政策進一步提升了市場准入。本地製造商和國際品牌都在投資產品在地化和教育,使亞太地區成為寵物CBD的關鍵成長中心。
在預測期內,北美預計將實現最高的複合年成長率,這主要得益於其先進的獸醫基礎設施、較高的消費者意識以及不斷完善的CBD相關立法。美國和加拿大引領寵物健康潮流,飼主積極尋求天然療法來緩解寵物的焦慮、疼痛和老齡化症狀。較高的可支配收入和高級產品的廣泛普及推動了CBD的快速普及。此外,強大的電子商務網路以及獸醫領域對CBD日益成長的接受度也是促成北美成為成長最快的區域市場的重要因素。
According to Stratistics MRC, the Global Pet CBD Products Market is accounted for $874.1 million in 2025 and is expected to reach $2,784.6 million by 2032 growing at a CAGR of 18.0% during the forecast period. Pet CBD products are hemp-derived formulations designed to support the health and wellness of companion animals such as dogs and cats. These products contain cannabidiol (CBD), a non-psychoactive compound known for its potential therapeutic benefits, including relief from anxiety, inflammation, pain, and seizures. Available in various forms-such as oils, treats, capsules, chews, and topicals-pet CBD products are formulated to be safe, legal (with less than 0.3% THC), and palatable for animals. They are increasingly used in holistic pet care routines, often under veterinary guidance, to enhance quality of life and manage chronic conditions without intoxicating effects.
Pet Humanization & Wellness Trends
The growing trend of pet humanization is a major driver of the pet CBD products market, as owners increasingly seek holistic wellness solutions for their animals. CBD products are viewed as natural alternatives for managing anxiety, pain, and age-related conditions. With pets treated as family members, demand for safe, non-intoxicating, and therapeutic formulations continues to rise. This shift in consumer behavior, supported by increased spending on pet healthcare and wellness, is fueling rapid market expansion across both developed and emerging regions.
Regulatory Ambiguity
Regulatory ambiguity remains a key restraint in the pet CBD products market. Varying legal frameworks across countries and states create uncertainty around product approval, labeling, and distribution. The lack of standardized guidelines for CBD use in animals limits veterinary endorsement and consumer confidence. Additionally, inconsistent enforcement and evolving legislation hinder market entry for new players and complicate expansion strategies. Until clearer regulations are established, this ambiguity will continue to challenge manufacturers, retailers, and pet owners seeking reliable CBD solutions.
Product Innovation & Branding
Product innovation and branding presents a significant opportunity for growth in the pet CBD market. Companies are developing diverse formats-such as flavored treats, oils, capsules, and topicals-tailored to pet preferences and health needs. Enhanced branding strategies, including transparency in sourcing and third-party testing, build consumer trust and loyalty. As awareness of CBD's benefits grows, innovative delivery systems and targeted formulations for specific conditions (e.g., joint pain, anxiety) are driving differentiation. This innovation wave is expected to accelerate adoption and expand market reach.
Limited Veterinary Endorsement
Limited veterinary endorsement poses a threat to the pet CBD products market, as many professionals remain cautious due to insufficient clinical data and regulatory risks. Without strong support from veterinarians, pet owners may hesitate to adopt CBD products, especially for chronic or serious conditions. This lack of medical validation affects credibility and slows mainstream acceptance. To overcome this barrier, companies must invest in research, education, and partnerships with veterinary institutions to build evidence-based support and encourage responsible usage.
The Covid-19 pandemic had a mixed impact on the pet CBD products market. While supply chain disruptions and economic uncertainty initially slowed growth, increased pet adoption and time spent at home boosted interest in wellness solutions. Owners became more attentive to pets' behavioral and health issues, driving demand for calming and therapeutic CBD products. E-commerce channels flourished during lockdowns, reshaping purchasing habits and expanding access. Post-pandemic recovery continues to support market momentum, with digital platforms and health-conscious consumers sustaining long-term growth.
The CBD isolate segment is expected to be the largest during the forecast period
The CBD isolate segment is expected to account for the largest market share during the forecast period, due to its purity, consistency, and legal compliance. Isolate formulations contain 99% pure CBD, free from THC and other cannabinoids, making them ideal for pet use. These products offer predictable dosing and minimal risk of psychoactive effects, which appeals to cautious pet owners and veterinarians. Their widespread availability across treats, oils, and capsules further supports dominance, especially in regions with strict regulatory standards.
The e-commerce segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the e-commerce segment is predicted to witness the highest growth rate, due to convenience, product variety, and digital awareness. Online platforms offer easy access to CBD products, along with educational content, reviews, and subscription models. The pandemic accelerated digital adoption, and consumers now prefer direct-to-door delivery for pet wellness items. E-commerce also enables niche brands to reach global audiences, bypassing traditional retail barriers. This shift in buying behavior is expected to sustain rapid growth and reshape distribution strategies.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising pet ownership, growing disposable incomes, and increasing awareness of natural health solutions. Countries like China, Japan, and India are experiencing a surge in pet humanization, driving demand for holistic care products. Expanding e-commerce infrastructure and favorable regulatory developments further enhance market accessibility. Local manufacturers and global brands are investing in product localization and education, positioning Asia Pacific as a key growth hub for pet CBD.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure, strong consumer awareness, and progressive CBD legislation. The U.S. and Canada lead in pet wellness trends, with owners actively seeking natural remedies for anxiety, pain, and aging-related conditions. High disposable incomes and widespread availability of premium products support rapid adoption. Additionally, robust e-commerce networks and increasing veterinary openness to CBD contribute to North America's position as the fastest-growing regional market.
Key players in the market
Some of the key players in Pet CBD Products Market include Charlotte's, Medterra, King Kanine, Pet Releaf, Innovet Pet, Green Roads, Honest Paws, cbdMD, Inc., CBDfx, Canna-Pet, Paw CBD, HempMy Pet, HolistaPet, Joy Organics and PureKana.
In September 2025, The multi-year partnership between Charlotte Hornets and Judi Health marks a strategic alignment of athletic branding and healthcare innovation: Judi Health becomes the exclusive jersey-patch partner for the Hornets, showcasing its healthcare-tech leadership on the NBA stage and amplifying its mission to transform benefit administration across the U.S.
In April 2025, Nutriband Inc. has entered into a partnership agreement with Charlotte FC, leveraging the collaboration to boost its brand visibility-particularly for its "AI Tape" product made in the Charlotte region-and spotlight its AVERSA(TM) abuse-deterrent patch technology.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.